Clinical Trials Browser

Breast Neoplasms

NCT01602380 2026-02-27

FALCON

Phase 3 Completed

462 enrolled 20 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02767661 2026-02-27

MECCA

Phase 3 Completed

263 enrolled

Breast

Breast Neoplasms

NCT03079011 2025-11-18

PADA-1

Phase 3 Completed

1,017 enrolled

Breast

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Phase 3 Completed

478 enrolled 16 charts 1 FDA

Breast

Breast Neoplasms

NCT00253422 2025-06-04

SoFEA

Phase 3 Completed

698 enrolled 19 charts

Breast

Breast Neoplasms

NCT00265759 2025-04-23

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 3 Completed

622 enrolled 18 charts

Breast

Breast Neoplasms

NCT00072462 2024-09-19

IBIS-II DCIS

Phase 3 Completed

2,980 enrolled 14 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Phase 3 Completed

1,803 enrolled 20 charts

Breast

Breast Neoplasms

NCT02278120 2024-03-12

MONALEESA-7

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Breast

Advanced Metastatic Breast Cancer

NCT00066573 2023-08-25

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer

Phase 3 Completed

7,576 enrolled 10 charts

Breast

Breast Neoplasms

NCT00301457 2023-02-21

DATA

Phase 3 Completed

1,914 enrolled

Breast

Breast Neoplasms

NCT00078832 2021-10-06

IBIS II

Phase 3 Completed

3,864 enrolled

Breast

Breast Neoplasms

NCT00075764 2021-01-13

S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

Phase 3 Completed

695 enrolled 15 charts

Breast

Breast Neoplasms

NCT02511639 2020-12-03

MAIN-A

Phase 3 Completed

110 enrolled

Breast

Breast Cancer Metastatic

NCT00295620 2019-10-02

SALSA

Phase 3 Completed

3,484 enrolled 18 charts

Breast

Breast Neoplasms

NCT02995772 2019-06-19

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Phase 3 Completed

122 enrolled

Breast

Breast Neoplasms

NCT00053898 2018-09-20

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Phase 3 Completed

3,104 enrolled 16 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00248170 2016-04-19

FACE

Phase 3 Completed

4,172 enrolled 7 charts

Breast

Breast Neoplasms

NCT00022672 2013-06-13

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Phase 3 Completed

208 enrolled 20 charts

Breast

Breast Neoplasms

NCT00291759 2013-01-30

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

Phase 3 Completed

3,858 enrolled

Breast

Breast Neoplasms

NCT00605267 2012-09-06

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

Phase 3 Completed

197 enrolled 23 charts

Breast

Breast Neoplasms, Neoplasms

NCT00256698 2012-08-01

FACT

Phase 3 Completed

514 enrolled 13 charts

Breast

Breast Neoplasms, Neoplasms, Recurrence

NCT00849030 2012-06-06

ATAC - Arimidex, Tamoxifen Alone or in Combination

Phase 3 Completed

9,358 enrolled

Breast

Breast Neoplasms

NCT00143390 2012-01-25

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

Phase 3 Completed

298 enrolled 13 charts

Breast

Breast Neoplasms

NCT00944918 2011-08-29

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

Phase 3 Completed

25 enrolled

Breast

Breast Neoplasms

NCT00327769 2011-01-25

Faslodex Advanced Breast Cancer Local Chinese Study

Phase 3 Completed

234 enrolled

Breast

Advanced Breast Cancer

NCT00232661 2010-02-03

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

Phase 3 Completed

452 enrolled

Breast

Breast Neoplasms

NCT00784862 2009-05-15

ATAC - Pharmacokinetics (PK) Sub-Protocol

Phase 3 Completed

9,358 enrolled

Breast

Breast Neoplasms

NCT00286117 2009-05-01

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

Phase 3 Completed

448 enrolled

Breast

Breast Neoplasms

NCT00300508 2009-05-01

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

Phase 3 Completed

856 enrolled

Breast

Breast Neoplasms

NCT00784680 2009-05-01

ATAC - Quality of Life Sub-Protocol

Phase 3 Completed

308 enrolled

Quality of Life

NCT00814125 2009-05-01

ATAC - Endometrial Sub-Protocol

Phase 3 Completed

285 enrolled

Breast

Breast Neoplasms

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

Phase 3 Completed

308 enrolled

Bone Density

NCT00635713 2009-04-10

Second Line Breast Cancer Trial

Phase 3 Completed

588 enrolled

Breast

Advanced Breast Cancer

Clinical Trials

MNEMOSYNE

FALCON

MECCA

PADA-1

EMERALD

SoFEA

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

IBIS-II DCIS

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

MONALEESA-7

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer

DATA

IBIS II

S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

MAIN-A

SALSA

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

FACE

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

FACT

ATAC - Arimidex, Tamoxifen Alone or in Combination

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

Faslodex Advanced Breast Cancer Local Chinese Study

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

ATAC - Pharmacokinetics (PK) Sub-Protocol

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

ATAC - Quality of Life Sub-Protocol

ATAC - Endometrial Sub-Protocol

ATAC - Bone Density Sub-Protocol

Second Line Breast Cancer Trial